2017 FDA New Drug Approvals - JA0008057-0000-19-263-H01-P

2017 FDA New Drug Approvals

by Jill M. O'Donnell, PharmD, BCPS, BCGP
JA0008057-0000-19-263-H01-P
(4.6 / 5 ratings )

This course is credentialed for:
Pharmacy (3.00 Contact Hr)

ONLINE
Price: $33.00
CE-PRO Price: $16.50

Summary:

Keeping up with the approval of new medications is one of the many challenges of pharmacists and other healthcare providers. As an expert in the field of drug information, a pharmacist plays a vital role in educating patients and other healthcare providers on new medication options. In 2017, the FDA approved 46 new medications to treat a wide variety of disease states, including cancers, multiple sclerosis, and hepatitis C. Many of these new medications will significantly change the way we treat these diseases. This course provides an overview of newly approved medications and their importance to patient care. Specific drug characteristics, the clinical trials that were pivotal to the drugs’ approval, and therapeutic use of drugs are discussed. 

Objectives:

The goal of this course is to educate healthcare professionals on new medications approved by the FDA in 2017. At the end of this course, you will be able to:
  • Discuss the therapeutic use for new drugs approved by the FDA in 2017.
  • Identify key clinical trials that brought these new medications to market.
  • Describe dosing and other caveats in therapy for first-in-class medications.
 

 
Accreditation Information
 
The course is intended for pharmacists
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Pharmacy (provider # 50-1489).
 
Type of Activity: Knowledge
 
Initial Release Date: 9/01/2019; Planned Expiration Date: 12/31/2019

Course Originally Released on: 9/5/2019
Date of Most Recent Review: 9/5/2019
Course Termination/Update Date: 12/31/2019

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

 

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Debra G - Fort Myers, FL  ·  Sep 15, 2019
very hard to understand the new drugs and there reactions.
Was this review helpful?  0
 
WAFA A - sharjah, IT  ·  Sep 14, 2019
Very good course and so usefull in medical practice
Was this review helpful?  0
 
Mary Grace S - Conshohocken, PA  ·  Sep 13, 2019
Difficult. Takes time to read and comprehend.
Was this review helpful?  0
 
REJI J - Darien, IL  ·  Sep 11, 2019
very good information about the new drugs that were approved, informative
Was this review helpful?  0
 
ONLINE
Price: $33.00
CE-PRO Price: $16.50